Skip to main content
Log in

Les cancers primitifs de l’urètre

Urethral Carcinoma

  • Mise au Point / Update
  • Published:
Oncologie

Résumé

Les cancers primitifs de l’urètre sont rares. Les données de la littérature sont limitées, et les recommandations sont de grades B et C. Un traitement conservateur peut être proposé pour les lésions localisées de l’urètre antérieur. Les lésions localement évoluées et celles de l’urètre postérieur relèvent d’une thérapie multimodale qui doit être discutée en réunion multidisciplinaire.

Abstract

Urethral carcinoma is a rare cancer. The published data on this topic are limited. Evidence-based information are of grade B and C. Sparing surgery can be an option for localized anterior tumors. For localized, advanced, and posterior tumors the treatment must be discussed by a multidisciplinary team, but the optimal treatment remains to be defined.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Références

  1. Avances C, Lesourd A, Michel F, et al. (2009) Tumeurs primitives de l’urètre. Épidémiologie, diagnostic et anatomopathologie. Recommandations du comité de cancérologie de l’Association française d’urologie. Prog Urol 19: 165–169

    Article  CAS  PubMed  Google Scholar 

  2. Carroll PR, Dixon CM (1992) Surgical anatomy of the male and female urethra. Urol Clin North Am 19: 339–346

    CAS  PubMed  Google Scholar 

  3. Champ CE, Hegarty SE, Shen X, et al. (2012) Prognostic factors and outcomes after definitive treatment of female urethral cancer: a population-based analysis. Urology 80: 374–381

    Article  PubMed  Google Scholar 

  4. Cheville JC, Dundore PA, Bostwick DG, et al. (1998) Transitional cell carcinoma of the prostate: clinicopathologic study of 50 cases. Cancer 82: 703–707

    Article  CAS  PubMed  Google Scholar 

  5. Cohen MS, Triaca V, Billmeyer B, et al. (2008) Coordinated chemoradiation therapy with genital preservation for the treatment of primary invasive carcinoma of the male urethra. J Urol 179: 536–541; discussion 541

    Article  CAS  PubMed  Google Scholar 

  6. Dalbagni G, Donat SM, Eschwege P, et al. (2001) Results of high dose rate brachytherapy, anterior pelvic exenteration and external beam radiotherapy for carcinoma of the female urethra. J Urol 166: 1759–1761

    Article  CAS  PubMed  Google Scholar 

  7. Dalbagni G, Zhang ZF, Lacombe L, et al. (1998) Female urethral carcinoma: an analysis of treatment outcome and a plea for a standardized management strategy. Br J Urol 82: 835–841

    Article  CAS  PubMed  Google Scholar 

  8. Dalbagni G, Zhang ZF, Lacombe L, et al. (1999) Male urethral carcinoma: analysis of treatment outcome. Urology 53: 1126–1132

    Article  CAS  PubMed  Google Scholar 

  9. Dayyani F, Pettaway CA, Kamat AM, et al. (2013) Retrospective analysis of survival outcomes and the role of cisplatin-based chemotherapy in patients with urethral carcinomas referred to medical oncologists. Urol Oncol 31: 1171–1177

    Article  CAS  PubMed  Google Scholar 

  10. Derksen JW, Visser O, de la Riviere GB, et al. (2013) Primary urethral carcinoma in females: an epidemiologic study on demographical factors, histological types, tumour stage and survival. World J Urol 31: 147–153

    Article  PubMed  Google Scholar 

  11. Dimarco DS, Dimarco CS, Zincke H, et al. (2004) Surgical treatment for local control of female urethral carcinoma. Urol Oncol 22: 404–409

    Article  PubMed  Google Scholar 

  12. Eble JNSG, Epstein JI, Sesterhenn IA (eds) (2004) Pathology and genetics of tumours of the urinary system and male genital organs. IARC World Health Organisation classification of tumours

    Google Scholar 

  13. Gakis G, Witjes JA, Comperat E, et al. (2013) EAU Guidelines on primary urethral carcinoma. Eur Urol 64: 823–830

    Article  PubMed  Google Scholar 

  14. Garden AS, Zagars GK, Delclos L (1993) Primary carcinoma of the female urethra. Results of radiation therapy. Cancer 71: 3102–3108

    Article  CAS  PubMed  Google Scholar 

  15. Gheiler EL, Tefilli MV, Tiguert R, et al. (1998) Management of primary urethral cancer. Urology 52: 487–493

    Article  CAS  PubMed  Google Scholar 

  16. Gofrit ON, Pode D, Pizov G, et al. (2009) Prostatic urothelial carcinoma: is transurethral prostatectomy necessary before bacillus Calmette-Guerin immunotherapy? BJU Int 103: 905–908

    Article  PubMed  Google Scholar 

  17. Gourtsoyianni S, Hudolin T, Sala E, et al. (2011) MRI at the completion of chemoradiotherapy can accurately evaluate the extent of disease in women with advanced urethral carcinoma undergoing anterior pelvic exenteration. Clin Radiol 66: 1072–1078

    Article  CAS  PubMed  Google Scholar 

  18. Hara I, Hikosaka S, Eto H, et al. (2004) Successful treatment for squamous cell carcinoma of the female urethra with combined radio- and chemotherapy. Int J Urol 11: 678–682

    Article  PubMed  Google Scholar 

  19. Hricak H, Secaf E, Buckley DW, et al. (1991) Female urethra: MR imaging. Radiology 178: 527–535

    CAS  PubMed  Google Scholar 

  20. Iborra F, Rigaud J, Bastide C, et al. (2009) Prise en charge thérapeutique des tumeurs de l’urètre. Recommandations du comité de cancérologie de l’Association française d’urologie. Prog Urol 19: 170–175

    Article  CAS  PubMed  Google Scholar 

  21. Karnes RJ, Breau RH, Lightner DJ (2010) Surgery for urethral cancer. Urol Clin North Am 37: 445–457

    Article  PubMed  Google Scholar 

  22. Koontz BF, Lee WR (2010) Carcinoma of the urethra: radiation oncology. Urol Clin North Am 37: 459–466

    Article  PubMed  Google Scholar 

  23. Lont AP, Besnard AP, Gallee MP, et al. (2003) A comparison of physical examination and imaging in determining the extent of primary penile carcinoma. BJU Int 91: 493–495

    Article  CAS  PubMed  Google Scholar 

  24. Nigro ND, Vaitkevicius VK, Considine B Jr (1989) Dynamic management of squamous cell cancer of the anal canal. Invest New Drugs 7: 83–89

    Article  CAS  PubMed  Google Scholar 

  25. Palou Redorta J, Schatteman P, Huguet Perez J, et al. (2006) Intravesical instillations with bacillus Calmette-Guerin for the treatment of carcinoma in situ involving prostatic ducts. Eur Urol 49: 834–838; discussion 838

    Article  PubMed  Google Scholar 

  26. Petralia G, Villa G, Scardino E, et al. (2008) Local staging of penile cancer using magnetic resonance imaging with pharmacologically induced penile erection. Radiol Med 113: 517–528

    Article  CAS  PubMed  Google Scholar 

  27. Rabbani F (2011) Prognostic factors in male urethral cancer. Cancer 117: 2426–2434

    Article  PubMed  Google Scholar 

  28. Smith Y, Hadway P, Ahmed S, et al. (2007) Penile-preserving surgery for male distal urethral carcinoma. BJU Int 100: 82–87

    Article  PubMed  Google Scholar 

  29. Swartz MA, Porter MP, Lin DW, et al. (2006) Incidence of primary urethral carcinoma in the United States. Urology 68: 1164–1168

    Article  PubMed  Google Scholar 

  30. Weghaupt K, Gerstner GJ, Kucera H (1984) Radiation therapy for primary carcinoma of the female urethra: a survey over 25 years. Gynecol Oncol 17: 58–63

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to F. Iborra.

About this article

Cite this article

Iborra, F., Murez, T., Millet, I. et al. Les cancers primitifs de l’urètre. Oncologie 16, 187–192 (2014). https://doi.org/10.1007/s10269-014-2387-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10269-014-2387-x

Mots clés

Keywords

Navigation